April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Patient age is not a significant barrier to adoption of customized scleral devices.
Author Affiliations & Notes
  • Eda Dou
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Daniel L Kornberg
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Yvonne Wang
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Ryan M St Clair
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Michelle Lee
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Mark I Rosenblatt
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Priyanka Sood
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Ana G Alzaga Fernandez
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Jessica B Ciralsky
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Kimberly C Sippel
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Footnotes
    Commercial Relationships Eda Dou, None; Daniel Kornberg, None; Yvonne Wang, None; Ryan St Clair, None; Michelle Lee, None; Mark Rosenblatt, None; Priyanka Sood, None; Ana Alzaga Fernandez, None; Jessica Ciralsky, None; Kimberly Sippel, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6055. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eda Dou, Daniel L Kornberg, Yvonne Wang, Ryan M St Clair, Michelle Lee, Mark I Rosenblatt, Priyanka Sood, Ana G Alzaga Fernandez, Jessica B Ciralsky, Kimberly C Sippel; Patient age is not a significant barrier to adoption of customized scleral devices.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6055.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare ease of adoption of a customized scleral device in patients of different ages.

Methods: Twenty-five patients (47 eyes) referred to the Weill Cornell Department of Ophthalmology for PROSE device fitting between July 1st, 2012 and July 1st, 2013 were enrolled in this study. Patients were categorized into the following age groups: <50 years (Group I), 50-60 years (Group II), and >60 years (Group III). Adoption of the customized scleral device was assessed by the length of time the device was worn per day, the amount of time needed to insert and remove the device, the difficulty of device insertion and removal as determined by subjective difficulty scores (1= no difficulty; 5= very difficult), and whether or not an assistant was needed for device insertion or removal. Data was collected from daily logs kept by patients during the fitting process and by patient interview when logs were not available. The length of the fitting process and the number of trial devices needed to find a suitable fit were also recorded for each patient upon completion of the fitting process.

Results: Differences in the daily length of device wear across the three age groups were significant only during the first week of the fitting process with daily averages of 10±2.2 h for Group I, 5.0±5.2 h for Group II, and 2.8±2.0 h for Group III. Daily averages for all age groups exceeded 7 h by week 2 and 9 h by week 3. Device insertion times were below 5 minutes for the majority of patients in all groups within the first week of fitting (100% for Group I; 60% for Group II; 87% for Group III), and by week 3 for device removal (100% for Group I; 83%, for Group II; 100% for Group III). Mean subjective difficulty rating for device insertion and removal remained below 2 for all groups throughout the duration of the fitting process, and no assistance was needed for any patient in any group. There were no significant differences found in the length of the fitting process or the number of trial devices needed among the age groups.

Conclusions: Patients in all age groups quickly adapted to wearing the device and to its insertion and removal. Our study suggests that age should not be a major barrier in considering customized scleral device treatment such as PROSE.

Keywords: 477 contact lens • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×